C326-0395 Screening compound: 10-(3-{[4-(3-methoxyphenyl)piperazino]carbonyl}phenyl)-4,9-dimethyl-8-oxa-10,12-diazatricyclo[7.3.1.0~2,7~]trideca-2,4,6-trien-11-one

C326-0395 Screening compound: 10-(3-{[4-(3-methoxyphenyl)piperazino]carbonyl}phenyl)-4,9-dimethyl-8-oxa-10,12-diazatricyclo[7.3.1.0~2,7~]trideca-2,4,6-trien-11-one
C326-0395 Screening compound: 10-(3-{[4-(3-methoxyphenyl)piperazino]carbonyl}phenyl)-4,9-dimethyl-8-oxa-10,12-diazatricyclo[7.3.1.0~2,7~]trideca-2,4,6-trien-11-one alternative view

Chemical Structure Depiction of ChemDiv screening compound C326-0395
10-(3-{[4-(3-methoxyphenyl)piperazino]carbonyl}phenyl)-4,9-dimethyl-8-oxa-10,12-diazatricyclo[7.3.1.0~2,7~]trideca-2,4,6-trien-11-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C326-0395

Molecular Formula

C30H32N4O4 (C30 H32 N4 O4)

Compound Name

10-(3-{[4-(3-methoxyphenyl)piperazino]carbonyl}phenyl)-4,9-dimethyl-8-oxa-10,12-diazatricyclo[7.3.1.0~2,7~]trideca-2,4,6-trien-11-one

IUPAC name

10-{3-[4-(3-methoxyphenyl)piperazine-1-carbonyl]phenyl}-49-dimethyl-8-oxa-1012-diazatricyclo[7.3.1.0^{27}]trideca-246-trien-11-one

SMILES

CC(CC1N2)(N(c3cc(C(N(CC4)CCN4c4cc(OC)ccc4)=O)ccc3)C2=O)Oc2c1cc(C)cc2

InChI

InChI=1S/C30H32N4O4/c1-20-10-11-27-25(16-20)26-19-30(2,38-27)34(29(36)31-26)23-8-4-6-21(17-23)28(35)33-14-12-32(13-15-33)22-7-5-9-24(18-22)37-3/h4-11,16-18,26H,12-15,19H2,1-3H3,(H,31,36)

InChI Key

YYRJPIRBAKMILZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14748960

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

512.61

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.467

Distribution Coefficient, logD

4.467

Water Solubility, LogSw

-4.39

Polar Surface Area

60.529

Acid Dissociation Constant (pKa)

13.10

Base Dissociation Constant (pKb)

2.03

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

33.30

C326-0395 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein-Protein Interaction Library (218420 compounds)

Purinergic Library (3321 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
Therapeutical areas:
  • Nervous system
  • Cardiovascular
  • Metabolic
Targets:
  • GPCR
  • Ion Channels
Structure:
  • Cyclic compounds
  • Cyclic compounds

References: we are preparing a list of scientific research reports with C326-0395 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C326-0395?
Check Price and Availability of C326-0395, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C326-0395 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C326-0395
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C326-0395
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C326-0395 available by request